1. Phase III ASAP trial
https://ash.confex.com/ash/2022/webprogram/Paper159962.html
2. Phase III Dauno-Double Trial
https://ash.confex.com/ash/2022/webprogram/Paper157126.html
3. Reduced venetoclax exposure:
https://ash.confex.com/ash/2022/webprogram/Paper165464.html
4. Menin Inhibitors in AML
https://ash.confex.com/ash/2022/webprogram/Paper164849.html
https://ash.confex.com/ash/2022/webprogram/Paper167412.html
5. Imetelstat in MDS: IMerge Phase 2
https://ash.confex.com/ash/2022/webprogram/Paper169050.html
6. MOMENTUM: Momelotinib
https://ash.confex.com/ash/2022/webprogram/Paper162783.html
How I manage anemia related to myelofibrosis and its treatment regimens
https://link.springer.com/article/10.1007/s00277-023-05126-4
